Anib 40 Mg (Afatinib) – 30 Tablets

Description

Anib Features:

Composition: Each Anib pill has 40 mg of Afatinib, which was carefully chosen to be absorbed and work well. Most of the time, the pills are oval and covered to make them easier to take.

Indications of Anib

Anib 40 mg is used to treat people with advanced NSCLC who have certain changes in the EGFR gene, which can be found by an FDA-approved test. It works especially well when other methods haven’t worked or aren’t right for the person.

Mechanism of Action

Afatinib binds to EGFR and other members of the ErbB family of receptors, irreversibly stopping their tyrosine kinase activity. By stopping the signalling pathways that help cancer cells grow and stay alive, this blocking slows the development of the disease.

Dosage and Administration:

The suggested daily amount of Anib is 40 mg taken by mouth. If possible, take the pills whole with water, ideally without food, at least one hour before or after a meal. Dose changes may be needed based on how each patient reacts and how well they can handle the medicine.

Anib Side Effects

Anib 40 mg can cause side effects like diarrhoea, rash, stomatitis (inflammation of the mouth), and paronychia (infection of the skin around the nails). Patients may also feel tired, have dry skin, and lose their appetite. Interstitial lung disease, liver function problems, and heart problems are some serious side effects that happen less often. It is important to get regular tracking and helpful care to deal with these bad affects.

Precautions

Before using Anib, patients should contact their doctor if they have any current medical disorders. This is especially important for conditions such as liver or renal difficulties, heart disease, or a history of lung illness. Women who can have children must use effective birth control while undergoing treatment with Afatinib. Additionally, they should continue using birth control for at least two weeks after their last dose. This is because the drug can harm a developing child. During treatment with Anib, you shouldn’t breastfeed.

Conclusion

Anib 40 mg is a targeted therapy for metastatic NSCLC patients with particular EGFR mutations. Its ability to stop cancer cells from using certain signalling pathways can help handle the disease and slow its growth, which is good for patients.

For More Medicine, Visit Our Shop